IDO1 and breast carcinoma: We used 1-D-MT because this stereoisomer is reportedly more effective in relieving T cell suppression mediated by IDO-expressing DCs in vitro and as an anticancer agent in chemoimmunotherapy of transplantable melanoma and transplantable and autochthonous breast cancer in mice [42].